Cordycepin Prevents Hyperlipidemia in Hamsters Fed a High-Fat Diet via Activation of AMP-Activated Protein Kinase
-
- Guo Peng
- Pharmacolog and Toxicology Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, China
-
- Kai Qu
- Key Laboratory of Natural Drugs Biosynthesis, Ministry of Health & Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, China
-
- Gao Jian
- Key Laboratory of Natural Drugs Biosynthesis, Ministry of Health & Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, China
-
- Lian Ze-qin
- Key Laboratory of Natural Drugs Biosynthesis, Ministry of Health & Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, China
-
- Wu Chong-ming
- Protein Science Laboratory of Ministry of Education, School of Life Sciences, Tsinghua University, China
-
- Wu Cheng-ai
- Department of Molecular Orthopaedics, Beijing Institute of Traumatology and Orthopaedics, China
-
- Zhu Hai-bo
- Key Laboratory of Natural Drugs Biosynthesis, Ministry of Health & Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, China
この論文をさがす
抄録
Hyperlipidemia is a major risk factor for cardiovascular diseases. In this study, we investigated the potential effects of cordycepin (3′-deoxyadenosine), a bioactive component of the fungus Cordyceps militaris, on hyperlipidemia. We found that in male Syrian golden hamsters fed a high-fat diet (HFD), daily administration of cordycepin effectively reduced the accumulation of serum total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-c) and suppressed HFD-associated increases in relative retroperitoneal fat. It also increased the levels of phospho–AMP-activated protein kinase (AMPK) and phospho–acetyl-CoA carboxylase (phospho-ACC) in liver and retroperitoneal adipose tissues. In HepG2 cells, cordycepin stimulated robust concentration- and time-dependent AMPK activation that correlated with the activation of ACC and the suppression of lipid biosynthesis. However, pretreatment with compound C, a specific inhibitor of AMPK, substantially abolished the effects of cordycepin on AMPK activation and lipid biosynthesis inhibition. These results indicate that cordycepin prevents hyperlipidemia via activation of AMPK. Experiments on abnormal metabolic mice indicated that cordycepin can also improve insulin sensitivity effectively.
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 113 (4), 395-403, 2010
公益社団法人 日本薬理学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001205179435264
-
- NII論文ID
- 10027746238
-
- NII書誌ID
- AA11806667
-
- COI
- 1:CAS:528:DC%2BC3cXhtFegtLvK
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 10790687
-
- PubMed
- 20724804
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可